Share
Share today's newsletter with a colleague and get credit if they sign up for SmartBrief.
Referral Count:
 
0

Story being shared
Researchers see promise in use of iPS cells for macular degeneration
An experimental therapy based on the use of skin cell-derived induced pluripotent stem cells has the potential to treat macular degeneration in people, according to a study published in Molecular Medicine. "With eye diseases, I think we're getting close to a scenario where a patient's own skin cells are used to replace retina cells destroyed by disease or degeneration," said Dr. Stephen Tsang of Columbia University Medical Center.

Or we can send an email on your behalf
You must submit valid email addresses only. Use of email addresses is subject to terms of SmartBrief's privacy policy .